CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 77 filers reported holding CYTOSORBENTS CORP in Q2 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $394,000 | 0.0% | 49,500 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $394,000 | +4825.0% | 49,500 | +2052.2% | 0.00% | – |
Q4 2019 | $8,000 | -63.6% | 2,300 | -50.0% | 0.00% | – |
Q3 2019 | $22,000 | +46.7% | 4,600 | +100.0% | 0.00% | – |
Q2 2019 | $15,000 | -75.8% | 2,300 | -72.3% | 0.00% | – |
Q1 2019 | $62,000 | -7.5% | 8,300 | 0.0% | 0.00% | – |
Q4 2018 | $67,000 | -37.4% | 8,300 | 0.0% | 0.00% | – |
Q3 2018 | $107,000 | +13.8% | 8,300 | 0.0% | 0.00% | – |
Q2 2018 | $94,000 | – | 8,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Skylands Capital, LLC | 815,869 | $3,141,000 | 0.46% |
Sargent Investment Group, LLC | 499,010 | $1,921,000 | 0.36% |
Anson Funds Management LP | 74,440 | $287,000 | 0.33% |
One68 Global Capital, LLC | 39,241 | $151,000 | 0.33% |
Granahan Investment Management | 678,618 | $2,613,000 | 0.12% |
Winning Points Advisors, LLC | 30,000 | $115,000 | 0.07% |
Avenir Corp | 150,600 | $580,000 | 0.06% |
HighMark Wealth Management LLC | 10,000 | $38,000 | 0.04% |
Wealthcare Advisory Partners LLC | 62,279 | $240,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 64,970 | $250,000 | 0.03% |